Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases

被引:257
|
作者
Bartels, Tim [1 ]
De Schepper, Sebastiaan [1 ]
Hong, Soyon [1 ]
机构
[1] UCL, UK Dementia Res Inst, Inst Neurol, London WC1E 6BT, England
基金
英国医学研究理事会;
关键词
ALPHA-SYNUCLEIN; NEURAL CIRCUITS; A-BETA; BRAIN; TREM2; GLUCOCEREBROSIDASE; MODELS; FORM; TAU;
D O I
10.1126/science.abb8587
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Dementia is a rapidly rising global health crisis that silently disables families and ends lives and livelihoods around the world. To date, however, no early biomarkers or effective therapies exist. It is now clear that brain microglia are more than mere bystanders or amyloid phagocytes; they can act as governors of neuronal function and homeostasis in the adult brain. Here, we highlight the fundamental role of microglia as tissue-resident macrophages in neuronal health. Then, we suggest how chronic impairment in microglia-neuron cross-talk may secure the permanence of the failure of synaptic and neuronal function and health in Alzheimer's and Parkinson's diseases. Understanding how to assess and modulate microglia-neuron interactions critical for brain health will be key to developing effective therapies for dementia.
引用
收藏
页码:66 / +
页数:4
相关论文
共 50 条
  • [1] Misframed Proteins and Neurodegeneration: A Novel View on Alzheimer's and Parkinson's Diseases
    Dennissen, F. J. A.
    Kholod, N.
    Steinbusch, H. W. M.
    Van Leeuwen, F. W.
    NEURODEGENERATIVE DISEASES, 2010, 7 (1-3) : 76 - 79
  • [2] Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases
    Hashimoto, M
    Rockenstein, E
    Crews, L
    Masliah, E
    NEUROMOLECULAR MEDICINE, 2003, 4 (1-2) : 21 - 35
  • [3] Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer’s and Parkinson’s diseases
    Makoto Hashimoto
    Edward Rockenstein
    Leslie Crews
    Eliezer Masliah
    NeuroMolecular Medicine, 2003, 4 : 21 - 35
  • [4] From cradle to grave: neurogenesis, neuroregeneration and neurodegeneration in Alzheimer's and Parkinson's diseases
    Debia Wakhloo
    Jane Oberhauser
    Angela Madira
    Sameehan Mahajani
    Neural Regeneration Research, 2022, 17 (12) : 2606 - 2614
  • [5] PARP-1 involvement in neurodegeneration: A focus on Alzheimer's and Parkinson's diseases
    Martire, Sara
    Mosca, Luciana
    d'Erme, Maria
    MECHANISMS OF AGEING AND DEVELOPMENT, 2015, 146 : 53 - 64
  • [6] From cradle to grave: neurogenesis, neuroregeneration and neurodegeneration in Alzheimer's and Parkinson's diseases
    Wakhloo, Debia
    Oberhauser, Jane
    Madira, Angela
    Mahajani, Sameehan
    NEURAL REGENERATION RESEARCH, 2022, 17 (12) : 2606 - 2614
  • [7] PROGRANULIN AND NEURODEGENERATION: LOWER SERUM LEVEL IN FRONTOTEMPORAL LOBAR DEGENERATION, PARKINSON'S AND ALZHEIMER'S DISEASES
    Mateo, I.
    Rueda, E.
    Pozueta, A.
    Vazquez-Higuera, J. L.
    Rodriguez-Rodriguez, E.
    Sanchez-Juan, P.
    Dobato, J. L.
    Calero, M.
    Berciano, J.
    Combarros, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 72 - 72
  • [8] Metals in Alzheimer's and Parkinson's diseases
    Barnham, Kevin J.
    Bush, Ashley I.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2008, 12 (02) : 222 - 228
  • [9] Pharmacogenomics of Alzheimer's and Parkinson's diseases
    Cacabelos, Ramon
    NEUROSCIENCE LETTERS, 2020, 726
  • [10] Cholesterol in Parkinson's and Alzheimer's diseases
    Mirnics, Zeljka K.
    Yan, Chaohua
    Schor, Nina F.
    ANNALS OF NEUROLOGY, 2006, 60 : S54 - S55